輸液療法市場- 世界の産業規模、シェア、動向、機会、予測、サービス別、コンポーネント別、エンドユーザー別、地域別、競合別、2020-2030年

輸液療法の世界市場規模は2024年に25億1,000万米ドル、2030年には39億4,000万米ドルに達し、CAGR 7.80％で成長すると予測されています。

この成長の主な要因は、慢性疾患の罹患率の増加、手術件数の増加、世界の静脈注射薬の承認件数の増加です。点滴治療クリニックの拡大も企業の地理的プレゼンスを高め、市場への浸透を後押ししています。さらに、静脈内治療の有効性と迅速な対応により、栄養失調の治療や、特に経口摂取が困難な患者に必要な栄養素を供給するための理想的なソリューションとなっています。点滴による栄養補給の必要性が高まる高齢化社会は、市場拡大にさらなる拍車をかけています。注目すべき例としては、Sameday Healthが2022年7月に発売したInner Beauty点滴が挙げられます。この点滴は、皮膚、爪、髪の健康状態の改善など、ウェルネスと美容上の利点を強調しており、予防とライフスタイルヘルスケアに対する消費者の関心の高まりを強調しています。

市場促進要因

慢性疾患と脱水症状の増加

主な市場課題

規制と安全性への懸念

主要市場動向

技術の進歩とサービスの革新

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の輸液療法市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • サービス別（免疫力アップ、エネルギーアップ、スキンケア、その他）
  • コンポーネント別（救急ヘルスケア、日常ヘルスケア）
  • エンドユーザー別（病院・クリニック、ウェルネスセンター・スパ、在宅ヘルスケア、その他）
  • 地域別（北米、欧州、アジア太平洋、南米、中東・アフリカ）
  • 企業別（2024）
• 市場マップ
• サービス別
• コンポーネント別
• エンドユーザー別
• 地域別

第6章 北米の輸液療法市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の輸液療法市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域の輸液療法市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の輸液療法市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの輸液療法市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 合併と買収
• 製品上市

第13章 世界の輸液療法市場：SWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• Core IV Therapy, LLC
• Cryojuvenate UK
• B. Braun SE
• Pfizer, Inc.
• JW Life Science
• Amanta Healthcare
• Vifor Pharma Management Ltd
• Otsuka Pharmaceutical Co., Ltd.
• Baxter
• ICU Medical, Inc.

第16章 戦略的提言

第17章 調査会社について・免責事項

The Global IV Hydration Therapy Market was valued at USD 2.51 billion in 2024 and is projected to reach USD 3.94 billion by 2030, growing at a CAGR of 7.80%. This growth is primarily attributed to the increasing incidence of chronic illnesses, rising surgical volumes, and the growing number of intravenous drug approvals worldwide. The expansion of IV therapy clinics is also enhancing companies' geographic presence, thereby boosting market penetration. Additionally, the effectiveness and quick response time of IV therapy make it an ideal solution for treating malnutrition and delivering essential nutrients, especially for patients unable to consume food orally. The aging population, with a heightened need for intravenous nutritional support, is further fueling market expansion. A notable example includes Sameday Health's launch of the Inner Beauty IV drip in July 2022, which emphasizes wellness and aesthetic benefits such as improved skin, nails, and hair health, highlighting the increasing consumer focus on preventive and lifestyle healthcare.

Key Market Drivers

Rising Prevalence of Chronic Diseases and Dehydration-Related Conditions

The growing global burden of chronic illnesses and dehydration-related issues significantly drives the demand for IV hydration therapy. Conditions like diabetes, kidney disease, and digestive disorders often result in fluid imbalances, making intravenous hydration essential for effective treatment. According to the World Health Organization, chronic diseases account for 71% of all global deaths, indicating a broad base of potential IV therapy patients. Dehydration is particularly prevalent among elderly individuals, athletes, and those under stress. The CDC reports that older adults are especially susceptible due to reduced thirst sensitivity and coexisting health conditions, which reinforces the importance of accessible and reliable hydration solutions through IV therapy.

Key Market Challenges

Regulatory and Safety Concerns

IV hydration therapy faces notable regulatory and safety obstacles that could impede market growth. A lack of consistent regulatory frameworks across different regions raises concerns about the quality and professionalism of services offered. In some areas, IV treatments are administered by staff lacking proper medical training, posing risks such as infections, vein inflammation, or electrolyte imbalances. Furthermore, the U.S. FDA has not approved IV hydration therapy for general wellness applications, underlining the need for more comprehensive clinical research to establish safety and efficacy. Addressing these challenges requires the implementation of standardized protocols and oversight to maintain patient safety and public trust.

Key Market Trends

Technological Advancements and Service Innovations

Innovations in technology are reshaping the IV hydration therapy market by making treatments more accessible and patient-centric. Portable infusion systems and integration with telemedicine platforms have enabled home-based treatments, broadening the reach of IV therapy. Additionally, clinics are increasingly offering personalized IV solutions tailored to specific wellness goals, such as immune support, detoxification, and anti-aging. This trend toward customization reflects the rising consumer demand for individualized healthcare experiences, helping drive adoption across various patient segments.

Key Market Players

• Core IV Therapy, LLC
• Cryojuvenate UK
• B. Braun SE
• Pfizer, Inc.
• JW Life Science
• Amanta Healthcare
• Vifor Pharma Management Ltd
• Otsuka Pharmaceutical Co., Ltd.
• Baxter
• ICU Medical, Inc.

Report Scope:

In this report, the Global IV Hydration Therapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

IV Hydration Therapy Market, By Service:

• Immune Booster
• Energy Booster
• Skin Care
• Others

IV Hydration Therapy Market, By Component:

• Emergency Healthcare
• Routine Healthcare

IV Hydration Therapy Market, By End User:

• Hospitals & Clinics
• Wellness Centers & Spa
• Home Healthcare
• Others

IV Hydration Therapy Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global IV Hydration Therapy Market.

Available Customizations:

Global IV Hydration Therapy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global IV Hydration Therapy Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Service (Immune Booster, Energy Booster, Skin Care, Others)
  • 5.2.2. By Component (Emergency Healthcare, Routine Healthcare)
  • 5.2.3. By End Users (Hospitals & Clinics, Wellness Centers & Spa, Home Healthcare, Others)
  • 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
  • 5.2.5. By Company (2024)
• 5.3. Market Map
• 5.3.1 By Service
• 5.3.2 By Component
• 5.3.3 By End Users
• 5.3.4 By Region

6. North America IV Hydration Therapy Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Service (Immune Booster, Energy Booster, Skin Care, Others)
  • 6.2.2. By Component (Emergency Healthcare, Routine Healthcare)
  • 6.2.3. By End Users (Hospitals & Clinics, Wellness Centers & Spa, Home Healthcare, Others)
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States IV Hydration Therapy Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Service
      • 6.3.1.2.2. By Component
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada IV Hydration Therapy Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Service
      • 6.3.2.2.2. By Component
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico IV Hydration Therapy Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Service
      • 6.3.3.2.2. By Component
      • 6.3.3.2.3. By End User

7. Europe IV Hydration Therapy Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Service (Immune Booster, Energy Booster, Skin Care, Others)
  • 7.2.2. By Component (Emergency Healthcare, Routine Healthcare)
  • 7.2.3. By End Users (Hospitals & Clinics, Wellness Centers & Spa, Home Healthcare, Others)
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France IV Hydration Therapy Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Service
      • 7.3.1.2.2. By Component
      • 7.3.1.2.3. By End User
  • 7.3.2. Germany IV Hydration Therapy Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Service
      • 7.3.2.2.2. By Component
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom IV Hydration Therapy Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Service
      • 7.3.3.2.2. By Component
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy IV Hydration Therapy Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Service
      • 7.3.4.2.2. By Component
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain IV Hydration Therapy Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Service
      • 7.3.5.2.2. By Component
      • 7.3.5.2.3. By End User

8. Asia-Pacific IV Hydration Therapy Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Service (Immune Booster, Energy Booster, Skin Care, Others)
  • 8.2.2. By Component (Emergency Healthcare, Routine Healthcare)
  • 8.2.3. By End Users (Hospitals & Clinics, Wellness Centers & Spa, Home Healthcare, Others)
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China IV Hydration Therapy Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Service
      • 8.3.1.2.2. By Component
      • 8.3.1.2.3. By End User
  • 8.3.2. India IV Hydration Therapy Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Service
      • 8.3.2.2.2. By Component
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan IV Hydration Therapy Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Service
      • 8.3.3.2.2. By Component
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea IV Hydration Therapy Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Service
      • 8.3.4.2.2. By Component
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia IV Hydration Therapy Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Service
      • 8.3.5.2.2. By Component
      • 8.3.5.2.3. By End User

9. South America IV Hydration Therapy Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Service (Immune Booster, Energy Booster, Skin Care, Others)
  • 9.2.2. By Component (Emergency Healthcare, Routine Healthcare)
  • 9.2.3. By End Users (Hospitals & Clinics, Wellness Centers & Spa, Home Healthcare, Others)
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil IV Hydration Therapy Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Service
      • 9.3.1.2.2. By Component
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina IV Hydration Therapy Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Service
      • 9.3.2.2.2. By Component
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia IV Hydration Therapy Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Service
      • 9.3.3.2.2. By Component
      • 9.3.3.2.3. By End User

10. Middle East and Africa IV Hydration Therapy Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Service (Immune Booster, Energy Booster, Skin Care, Others)
  • 10.2.2. By Component (Emergency Healthcare, Routine Healthcare)
  • 10.2.3. By End Users (Hospitals & Clinics, Wellness Centers & Spa, Home Healthcare, Others)
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa IV Hydration Therapy Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Service
      • 10.3.1.2.2. By Component
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia IV Hydration Therapy Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Service
      • 10.3.2.2.2. By Component
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE IV Hydration Therapy Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Service
      • 10.3.3.2.2. By Component
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global IV Hydration Therapy Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Core IV Therapy, LLC
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Cryojuvenate UK
• 15.3. B. Braun SE
• 15.4. Pfizer, Inc.
• 15.5. JW Life Science
• 15.6. Amanta Healthcare
• 15.7. Vifor Pharma Management Ltd
• 15.8. Otsuka Pharmaceutical Co., Ltd.
• 15.9. Baxter
• 15.10. ICU Medical, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer